Home » Topics » BioWorld Science

BioWorld Science
RSS

Vonoprazan noninferior to lansoprazole in phase III erosive esophagitis study

June 8, 2018

MannKind announces completion of phase I study of TreT in pulmonary arterial hypertension

June 8, 2018

Biogen enters agreement to acquire stroke drug candidate from TMS

June 8, 2018

FDA awards orphan drug designation to brincidofovir for the treatment of smallpox

June 8, 2018

Selinexor liposarcoma trial advances after improvement seen in progression-free survival

June 7, 2018

Enrollment ongoing in phase III study of pertuzumab and trastuzumab fixed-dose combination

June 7, 2018

GlaxoSmithKline initiates phase I study of GSK-3858279

June 7, 2018

Phase II results presented for TAK-954 in patients with enteral feeding intolerance

June 7, 2018

Athersys expands its collaboration with Healios

June 7, 2018

EMA grants PRIME designation for dilanubicel

June 7, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...